Skip to main content
EuroGCT
Menu
Close
Help and support
Help and support
FAQ's
Glossary
FAQ's
How is the safety of a new gene therapy determined?
How are gene and cell therapies different to 'traditional' therapies?
Where do embryonic stem cells for research come from?
How is the production of gene and cell therapies different to traditional treatments?
Why do we need gene and cell therapies? How are they different from traditional medicines and treatments?
What is genetic testing?
Is it ethical to use animals in health and scientific research?
What are the roles of regulators in the development of gene and cell therapies?
See all FAQs
Glossary
Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising
Antibody
See full Glossary
Search
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Condition
Blood disorders
Sickle Cell Disease
Cardiovascular Disease
Heart Disease
Stroke
Bowel Disease
Cancer
Cystic Fibrosis
Eye Disease
Immune Conditions
Diabetes
Multiple Sclerosis
Kidney Disease
Liver Disease
Lung Disease
Bone and Muscle Conditions
Muscular Dystrophy
Spinal Cord Injuries
Neurological Disorders
Alzheimer's Disease
Cerebral Palsy
Huntington's Disease
Motor Neurone Disease
Parkinson's Disease
Spinal Muscular Atrophy
Skin
Epidermolysis Bullosa
Reproduction and Fertility
Theme
Cell and Gene Fundamentals
Blood Stem Cells
Cord Blood
Embryonic Stem Cells
iPS cells
MSCs
Skin Stem Cells
Current and Potential Uses
Cell Therapy
Gene Therapy
Clinical Trials
CAR-T Therapy
Methods and Tools
Disease Modelling
Organoids
Tissue Engineering
Gene Editing
Reprogramming
Ethics and Society
Patient Involvement
Policy & Regulation
Unproven Treatments
Factsheets
Spotlight on Research
Main navigation
Discover
Discover
Educational Resources Directory
INTENS
LEARN
Research Pathways
Research Pathways
EuroGCT Key Resources
ATMP Engage
CARTALLEU
Actors and Network database
About Us
Contact
Breadcrumb
Home
Methods and Tools
Reprogramming
Reprogramming
Resources & Factsheets
What is CAR T-cell therapy?
Related Topics
Blood disorders
Cancer
Blood Stem Cells
CAR-T Therapy
Current and Potential Uses
Reprogramming
CAR T-cell therapy phases
Related Topics
Blood disorders
Cancer
CAR-T Therapy
Gene Editing
Reprogramming
English
EuroGCT Resource
Using 'reprogrammed' cells to model diseases
Related Topics
Current and Potential Uses
Disease Modelling
iPS cells
Methods and Tools
Organoids
Reprogramming
Tissue Engineering
The ISSCR Guide to Stem Cell Treatments
Related Topics
Blood Stem Cells
Cell Therapy
Clinical Trials
Embryonic Stem Cells
Ethics and Society
iPS cells
Patient Involvement
Reprogramming
Skin Stem Cells
Stem Cell News
English
EuroGCT Resource
Parkinson's Disease: How could gene and cell therapy help?
Related Topics
Neurological Disorders
Parkinson's Disease
Cell Therapy
Clinical Trials
Current and Potential Uses
Factsheets
Gene Therapy
iPS cells
Reprogramming
Connecting young people with Type 1 Diabetes through science
Related Topics
Diabetes
Cell Therapy
Current and Potential Uses
Embryonic Stem Cells
Patient Involvement
Reprogramming
Research
Stem Cell News
Gene Therapy Approaches
Related Topics
Cell Therapy
Current and Potential Uses
Gene Editing
Gene Therapy
Reprogramming
EuroGCT Resource
Stem cell futures: An introduction to iPS cells
Related Topics
Current and Potential Uses
Explore Stem Cells
iPS cells
Methods and Tools
Reprogramming
Vectors 101
Related Topics
Cell Therapy
Disease Modelling
Gene Editing
Gene Therapy
Methods and Tools
Reprogramming
EuroStemCell Resource
Reproduction and Fertility: How could stem cells help?
Related Topics
Reproduction and Fertility
Current and Potential Uses
Explore Stem Cells
Factsheets
iPS cells
Reprogramming
Pagination
Page
1
Page
2
Next page
››
Last page
Last »